nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxybutynin—CHRM2—forebrain—attention deficit hyperactivity disorder	0.00528	0.0794	CbGeAlD
Oxybutynin—CHRM1—forebrain—attention deficit hyperactivity disorder	0.00481	0.0722	CbGeAlD
Oxybutynin—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.00446	0.0671	CbGeAlD
Oxybutynin—CHRM3—forebrain—attention deficit hyperactivity disorder	0.0043	0.0646	CbGeAlD
Oxybutynin—CHRM5—nervous system—attention deficit hyperactivity disorder	0.00417	0.0628	CbGeAlD
Oxybutynin—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.00406	0.0611	CbGeAlD
Oxybutynin—CHRM5—central nervous system—attention deficit hyperactivity disorder	0.00402	0.0604	CbGeAlD
Oxybutynin—CHRM5—brain—attention deficit hyperactivity disorder	0.00319	0.048	CbGeAlD
Oxybutynin—CHRM2—nervous system—attention deficit hyperactivity disorder	0.00287	0.0431	CbGeAlD
Oxybutynin—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.00276	0.0415	CbGeAlD
Oxybutynin—CHRM1—nervous system—attention deficit hyperactivity disorder	0.00261	0.0392	CbGeAlD
Oxybutynin—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.00251	0.0378	CbGeAlD
Oxybutynin—CHRM3—nervous system—attention deficit hyperactivity disorder	0.00233	0.0351	CbGeAlD
Oxybutynin—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.00233	0.035	CbGeAlD
Oxybutynin—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.00225	0.0338	CbGeAlD
Oxybutynin—CHRM2—brain—attention deficit hyperactivity disorder	0.00219	0.0329	CbGeAlD
Oxybutynin—CHRM1—brain—attention deficit hyperactivity disorder	0.00199	0.03	CbGeAlD
Oxybutynin—CHRM3—brain—attention deficit hyperactivity disorder	0.00178	0.0268	CbGeAlD
Oxybutynin—CYP2C8—brain—attention deficit hyperactivity disorder	0.00145	0.0218	CbGeAlD
Oxybutynin—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00128	0.0193	CbGeAlD
Oxybutynin—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00126	0.019	CbGeAlD
Oxybutynin—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00123	0.0186	CbGeAlD
Oxybutynin—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00122	0.0183	CbGeAlD
Oxybutynin—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00119	0.0179	CbGeAlD
Oxybutynin—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00108	0.00116	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00108	0.00116	CbGpPWpGaD
Oxybutynin—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00107	0.00115	CbGpPWpGaD
Oxybutynin—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00107	0.00115	CbGpPWpGaD
Oxybutynin—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00106	0.00114	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00106	0.00113	CbGpPWpGaD
Oxybutynin—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00104	0.00111	CbGpPWpGaD
Oxybutynin—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00104	0.00111	CbGpPWpGaD
Oxybutynin—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00103	0.0011	CbGpPWpGaD
Oxybutynin—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00102	0.0011	CbGpPWpGaD
Oxybutynin—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00102	0.00109	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00102	0.00109	CbGpPWpGaD
Oxybutynin—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00101	0.00108	CbGpPWpGaD
Oxybutynin—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00101	0.00108	CbGpPWpGaD
Oxybutynin—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00101	0.00108	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00101	0.00108	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.001	0.00108	CbGpPWpGaD
Oxybutynin—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000997	0.00107	CbGpPWpGaD
Oxybutynin—CHRM1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000995	0.00107	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000994	0.00106	CbGpPWpGaD
Oxybutynin—CHRM3—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000992	0.00106	CbGpPWpGaD
Oxybutynin—CYP2D6—brain—attention deficit hyperactivity disorder	0.000965	0.0145	CbGeAlD
Oxybutynin—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000957	0.00103	CbGpPWpGaD
Oxybutynin—CYP2C8—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000954	0.00102	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000952	0.00102	CbGpPWpGaD
Oxybutynin—CYP2C8—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000948	0.00102	CbGpPWpGaD
Oxybutynin—CYP2C8—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000941	0.00101	CbGpPWpGaD
Oxybutynin—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000941	0.00101	CbGpPWpGaD
Oxybutynin—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000938	0.001	CbGpPWpGaD
Oxybutynin—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000936	0.001	CbGpPWpGaD
Oxybutynin—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000929	0.000995	CbGpPWpGaD
Oxybutynin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00089	0.000953	CbGpPWpGaD
Oxybutynin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000887	0.00095	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00088	0.000943	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000877	0.00094	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000869	0.000931	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000838	0.000898	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000835	0.000895	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000827	0.000886	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000821	0.000879	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000818	0.000877	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000818	0.000876	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000816	0.000874	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00081	0.000868	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000808	0.000866	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000808	0.000865	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000792	0.000849	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00079	0.000846	CbGpPWpGaD
Oxybutynin—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000783	0.000839	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000782	0.000838	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000779	0.000834	CbGpPWpGaD
Oxybutynin—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000778	0.000833	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000776	0.000832	CbGpPWpGaD
Oxybutynin—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000773	0.000828	CbGpPWpGaD
Oxybutynin—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000769	0.000824	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000769	0.000824	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000769	0.000824	CbGpPWpGaD
Oxybutynin—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000767	0.000821	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000767	0.000821	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000761	0.000815	CbGpPWpGaD
Oxybutynin—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000759	0.000813	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000759	0.000813	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000758	0.000812	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000751	0.000805	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000745	0.000799	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000743	0.000796	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000743	0.000796	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000736	0.000788	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000734	0.000786	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000717	0.000768	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000714	0.000765	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000713	0.000764	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000707	0.000758	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000706	0.000757	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00067	0.000718	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000668	0.000716	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000661	0.000709	CbGpPWpGaD
Oxybutynin—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000659	0.000706	CbGpPWpGaD
Oxybutynin—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000657	0.000704	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000657	0.000703	CbGpPWpGaD
Oxybutynin—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000651	0.000697	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000641	0.000687	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000638	0.000684	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000636	0.000681	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000625	0.00067	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000625	0.00067	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000617	0.000661	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000613	0.000657	CbGpPWpGaD
Oxybutynin—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000602	0.000645	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000596	0.000639	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000577	0.000619	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000575	0.000616	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000569	0.000609	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000568	0.000608	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000567	0.000608	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000562	0.000602	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000561	0.000601	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000536	0.000574	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000523	0.00056	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000522	0.000559	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000521	0.000559	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000517	0.000553	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000516	0.000553	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000515	0.000552	CbGpPWpGaD
Oxybutynin—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000512	0.000549	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00051	0.000546	CbGpPWpGaD
Oxybutynin—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000509	0.000545	CbGpPWpGaD
Oxybutynin—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000505	0.000541	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000502	0.000538	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.0005	0.000536	CbGpPWpGaD
Oxybutynin—CHRM1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000498	0.000533	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000497	0.000533	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000496	0.000531	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000495	0.000531	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000491	0.000526	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000462	0.000495	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000461	0.000494	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000456	0.000489	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000452	0.000484	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000451	0.000483	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00045	0.000482	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000449	0.000481	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000448	0.00048	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000448	0.00048	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000446	0.000478	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000446	0.000478	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000444	0.000475	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000442	0.000474	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00044	0.000472	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00044	0.000471	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000439	0.00047	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000439	0.00047	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000435	0.000466	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000435	0.000466	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000434	0.000465	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000433	0.000464	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000433	0.000464	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000432	0.000463	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00043	0.000461	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000429	0.00046	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000426	0.000457	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00042	0.00045	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000419	0.000448	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000414	0.000444	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000407	0.000436	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000405	0.000434	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000405	0.000434	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000404	0.000432	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000403	0.000432	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000401	0.00043	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.0004	0.000428	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.0004	0.000428	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000398	0.000427	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000395	0.000423	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000395	0.000423	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000393	0.000422	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00039	0.000418	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00039	0.000417	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000379	0.000406	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00037	0.000396	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00037	0.000396	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000368	0.000394	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000367	0.000393	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000366	0.000392	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000364	0.00039	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000363	0.000389	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000352	0.000377	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000341	0.000365	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000338	0.000362	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000335	0.000359	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000331	0.000355	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00032	0.000343	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000311	0.000333	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000311	0.000333	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000309	0.000331	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000306	0.000328	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000305	0.000327	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000304	0.000326	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000301	0.000323	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000296	0.000317	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000284	0.000305	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000284	0.000304	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000283	0.000303	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000281	0.000302	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00028	0.0003	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000269	0.000289	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000269	0.000289	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000267	0.000286	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000266	0.000285	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000265	0.000284	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000263	0.000282	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000258	0.000276	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000257	0.000275	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000254	0.000272	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000249	0.000266	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000248	0.000266	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000247	0.000265	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000246	0.000264	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000245	0.000262	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00024	0.000257	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000239	0.000256	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000237	0.000254	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000237	0.000254	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000236	0.000253	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000235	0.000252	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000233	0.00025	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000233	0.00025	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000232	0.000249	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00023	0.000247	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000224	0.00024	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000222	0.000238	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000221	0.000237	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000221	0.000237	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000218	0.000233	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000217	0.000233	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000217	0.000232	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000216	0.000231	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000215	0.000231	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000214	0.00023	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000209	0.000224	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000205	0.00022	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000202	0.000217	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	0.000188	0.000202	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000187	0.0002	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000177	0.000189	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000168	0.00018	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	0.000163	0.000175	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000162	0.000174	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000157	0.000168	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000152	0.000163	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000152	0.000162	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00015	0.000161	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000145	0.000155	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000145	0.000155	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000142	0.000152	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000134	0.000144	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000133	0.000143	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000132	0.000142	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000116	0.000124	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000114	0.000123	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00011	0.000118	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	9.61e-05	0.000103	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	8.76e-05	9.38e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	8.7e-05	9.32e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	8.08e-05	8.66e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.06e-05	8.63e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.03e-05	8.61e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.96e-05	8.52e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	7e-05	7.5e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	5.75e-05	6.15e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	3.76e-05	4.02e-05	CbGpPWpGaD
